1. Cancer and diabetes: are we ready for prime time?

   • U. Smith
   • E. A. M. Gale

   Commentary 13 June 2010 Pages: 1541 - 1544

2. Vitamin D and diabetes: the devil is in the D-tails

   • C. Mathieu

   Commentary 21 May 2010 Pages: 1545 - 1548

   

3. Zinc, zinc transporters and diabetes

   • J. Rungby

   Commentary 21 May 2010 Pages: 1549 - 1551

4. The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence

   • C. Nordin

   Review 21 April 2010 Pages: 1552 - 1561

   

5. Is there an impatience genotype leading to non-adherence to long-term therapies?

   • G. Reach

   Personal View 21 April 2010 Pages: 1562 - 1567

   

6. Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals

   • A. Zanchi
   • M. Maillard
   • A. Pechere-Bertschi

   Article 23 April 2010 Pages: 1568 - 1575

   

7. Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial

   • F. Persson
   • P. Rossing
   • H.-H. Parving

   Short Communication 18 May 2010 Pages: 1576 - 1580

   

8. Cardiovascular disease risk factors, depression symptoms and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes

   • R. R. Rubin
   • S. A. Gaussoin
   • for the Look AHEAD Research Group

   Article 28 April 2010 Pages: 1581 - 1589

9. Coping style and depression influence the healing of diabetic foot ulcers: observational and mechanistic evidence

   • K. Vedhara
   • J. N. V. Miles
   • R. Campbell

   Article 22 April 2010 Pages: 1590 - 1598

   

10. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring

    • L. Marjamäki
    • S. Niinistö
    • S. M. Virtanen

    Article 06 April 2010 Pages: 1599 - 1607

11. Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA_1c: the A1C-Derived Average Glucose (ADAG) study

    • R. Borg
    • J. C. Kuenen
    • on behalf of the ADAG Study Group

    Short Communication Open access 16 April 2010 Pages: 1608 - 1611

    

12. Changes in short- and long-term cardiovascular risk of incident diabetes and incident myocardial infarction—a nationwide study

    • M. L. Norgaard
    • S. S. Andersen
    • G. H. Gislason

    Article 09 May 2010 Pages: 1612 - 1619

    

13. Physical activity, obesity and cardiometabolic risk factors in 9- to 10-year-old UK children of white European, South Asian and black African-Caribbean origin: the Child Heart And health Study in England (CHASE)

    • C. G. Owen
    • C. M. Nightingale
    • P. H. Whincup

    Article Open access 09 May 2010 Pages: 1620 - 1630

    

14. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure

    • S. L. Bowker
    • Y. Yasui
    • J. A. Johnson

    Article 21 April 2010 Pages: 1631 - 1637

15. The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes

    • R. Klein
    • M. D. Knudtson
    • M. Mauer

    Article 01 May 2010 Pages: 1638 - 1646

    

16. Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people

    • T. W. Boesgaard
    • N. Grarup
    • O. Pedersen

    Article 26 April 2010 Pages: 1647 - 1655

    

17. Beta cell-specific Znt8 deletion in mice causes marked defects in insulin processing, crystallisation and secretion

    • N. Wijesekara
    • F. F. Dai
    • M. B. Wheeler

    Article 28 April 2010 Pages: 1656 - 1668

    

18. In vivo non-viral gene delivery of human vascular endothelial growth factor improves revascularisation and restoration of euglycaemia after human islet transplantation into mouse liver

    • M. Shimoda
    • S. Chen
    • P. A. Grayburn

    Article 20 April 2010 Pages: 1669 - 1679

    

19. Reciprocal modulation of adult beta cell maturity by activin A and follistatin

    • M. Szabat
    • J. D. Johnson
    • J. M. Piret

    Article 04 May 2010 Pages: 1680 - 1689

    

20. Human islet cell implants in a nude rat model of diabetes survive better in omentum than in liver with a positive influence of beta cell number and purity

    • D. Jacobs-Tulleneers-Thevissen
    • K. Bartholomeus
    • D. Pipeleers

    Article 16 April 2010 Pages: 1690 - 1699

    

21. A family history of type 2 diabetes increases risk factors associated with overfeeding

    • D. Samocha-Bonet
    • L. V. Campbell
    • L. K. Heilbronn

    Article 12 May 2010 Pages: 1700 - 1708

    

22. A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)–Botnia study

    • B. Isomaa
    • B. Forsén
    • L. C. Groop

    Short Communication 08 May 2010 Pages: 1709 - 1713

23. Exercise training increases mitochondrial content and ex vivo mitochondrial function similarly in patients with type 2 diabetes and in control individuals

    • E. Phielix
    • R. Meex
    • P. Schrauwen

    Article Open access 27 April 2010 Pages: 1714 - 1721

    

24. Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide

    • M. Whiteman
    • K. M. Gooding
    • A. C. Shore

    Article 23 April 2010 Pages: 1722 - 1726

    

25. Angiotensin II type 1 receptor-independent beneficial effects of telmisartan on dietary-induced obesity, insulin resistance and fatty liver in mice

    • X. Rong
    • Y. Li
    • K. Nakao

    Short Communication 15 April 2010 Pages: 1727 - 1731

    

26. IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise

    • L. Fritsche
    • M. Hoene
    • C. Weigert

    Article 22 April 2010 Pages: 1732 - 1742

    

27. Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling

    • L. Sciacca
    • M. F. Cassarino
    • R. Vigneri

    Article 28 April 2010 Pages: 1743 - 1753

    

28. Bone status in adolescents with type 1 diabetes

    • A. P. Chobot
    • A. Haffke
    • W. Pluskiewicz

    Article 09 May 2010 Pages: 1754 - 1760

    

29. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein

    • R. S. Mughal
    • J. L. Scragg
    • K. E. Porter

    Article Open access 12 May 2010 Pages: 1761 - 1771

    

30. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury

    • A. K. H. Lim
    • F. Y. Ma
    • G. H. Tesch

    Article 27 April 2010 Pages: 1772 - 1782

    

31. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes

    • A. Makino
    • B. T. Scott
    • W. H. Dillmann

    Article Open access 13 May 2010 Pages: 1783 - 1794

    

32. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet

    • J. A. Ehses
    • D. T. Meier
    • Marc Y. Donath

    Article 21 April 2010 Pages: 1795 - 1806

    

33. Obstructive sleep apnoea and the orexigenic pathway in type 2 diabetes

    • M. K. S. Leow

    Letter 08 May 2010 Pages: 1807 - 1808

34. Prevention strategies for type 2 diabetes should be based on evidence-based medical nutrition data

    • M. Uusitupa
    • J. Lindström
    • J. Tuomilehto

    Letter 08 May 2010 Pages: 1809 - 1810

35. Erratum to: Dimorphic histopathology of long-standing childhood-onset diabetes

    • R. Gianani
    • M. Campbell-Thompson
    • G. S. Eisenbarth

    Erratum 05 June 2010 Pages: 1811 - 1812

36. Erratum to: Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

    • G. Schernthaner
    • A. H. Barnett
    • R. DeFronzo

    Erratum 25 May 2010 Pages: 1813 - 1813